Search research articles
Contact Us
Filters
Showing results (171-180 of 185) with videos related to
Page
of 19
Sort By:
Blood
|
January 29, 2021
A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma
Di Wang, Jue Wang, Guang Hu, et al.
Nature Communications
|
November 6, 2024
Rationally designed multimeric nanovaccines using icosahedral DNA origami for display of SARS-CoV-2 receptor binding domain
Qingqing Feng, Keman Cheng, Lizhuo Zhang, et al.
Cell Reports
|
January 26, 2022
Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2
Huanhuan Zhao, Jun Lu, Tong Yan, et al.
The Journal of Allergy and Clinical Immunology
|
May 30, 2020
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
Yang Cao, Jia Wei, Liang Zou, et al.
Transplantation and Cellular Therapy
|
August 23, 2021
CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas
Yang Cao, Yi Xiao, Na Wang, et al.
Cell Reports
|
October 18, 2023
Functional diversification and dynamics of CAR-T cells in patients with B-ALL
Zongcheng Li, Lei Zhao, Yuanyuan Zhang, et al.
Cell Stem Cell
|
March 22, 2025
Vagal pathway activation links chronic stress to decline in intestinal stem cell function
Guoying Zhang, Yannan Lian, Qingguo Li, et al.
The Journal of Experimental Medicine
|
December 5, 2024
Tumor-associated neutrophils attenuate the immunosensitivity of hepatocellular carcinoma
Jia Ming Nickolas Teo, Zhulin Chen, Weixin Chen, et al.
Respiratory Research
|
January 18, 2025
Neutrophil elastase inhibitor (Sivelestat) in the treatment of acute respiratory distress syndrome induced by COVID-19: a multicenter retrospective cohort study
Yuting Li, Jianjun Zhao, Jiahui Wei, et al.
Blood
|
November 8, 2019
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies
Na Wang, Xuelian Hu, Wenyue Cao, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 185) with videos related to
Sort By:
Page
of 19
Blood
|
January 29, 2021
A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma
Di Wang, Jue Wang, Guang Hu, et al.
Nature Communications
|
November 6, 2024
Rationally designed multimeric nanovaccines using icosahedral DNA origami for display of SARS-CoV-2 receptor binding domain
Qingqing Feng, Keman Cheng, Lizhuo Zhang, et al.
Cell Reports
|
January 26, 2022
Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2
Huanhuan Zhao, Jun Lu, Tong Yan, et al.
The Journal of Allergy and Clinical Immunology
|
May 30, 2020
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
Yang Cao, Jia Wei, Liang Zou, et al.
Transplantation and Cellular Therapy
|
August 23, 2021
CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas
Yang Cao, Yi Xiao, Na Wang, et al.
Cell Reports
|
October 18, 2023
Functional diversification and dynamics of CAR-T cells in patients with B-ALL
Zongcheng Li, Lei Zhao, Yuanyuan Zhang, et al.
Cell Stem Cell
|
March 22, 2025
Vagal pathway activation links chronic stress to decline in intestinal stem cell function
Guoying Zhang, Yannan Lian, Qingguo Li, et al.
The Journal of Experimental Medicine
|
December 5, 2024
Tumor-associated neutrophils attenuate the immunosensitivity of hepatocellular carcinoma
Jia Ming Nickolas Teo, Zhulin Chen, Weixin Chen, et al.
Respiratory Research
|
January 18, 2025
Neutrophil elastase inhibitor (Sivelestat) in the treatment of acute respiratory distress syndrome induced by COVID-19: a multicenter retrospective cohort study
Yuting Li, Jianjun Zhao, Jiahui Wei, et al.
Blood
|
November 8, 2019
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies
Na Wang, Xuelian Hu, Wenyue Cao, et al.
Page
of 19